Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Convertible Loan Notes update

13 Jun 2017 07:00

RNS Number : 8750H
Kin Group PLC
13 June 2017
 

Kin Group Plc / Epic: KIN / Index: AIM

 

RNS ANNOUNCEMENT: The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

13 June 2017

 

KIN GROUP PLC ('KIN' OR 'THE COMPANY')

 

Convertible Loan Notes update

On 15 May 2017, Kin Group Plc (AIM: KIN), the AIM quoted digital wellness provider for corporate organisations trading as Kin Wellness, announced that it had agreed to issue convertible unsecured loan notes with a term of three years ("Notes"), to raise up to £1.125 million (before expenses) in four tranches, to Belastock Capital L.P., an overseas based institutional investor ("Belastock") to fund its general working capital requirements.

The issue of the Notes was subject to the terms and conditions summarised in the announcement dated 15 May. The first tranche of Notes with a nominal amount of £350,000 and a subscription price of £315,000 ("Tranche 1 Notes") were issued on 15 May 2017 with the remaining three tranches being issued at 60 day intervals thereafter.

One of the conditions attaching to the issue of subsequent Notes, which can be waived by Belastock, is that the closing bid price of the Company's ordinary shares (as reported by Bloomberg) falls below £0.001 (0.1 pence) for any five (5) consecutive trading days on or prior to the relevant issue date. The Company notes that this condition was not met at the close of business last night, 12 June 2017.

Notwithstanding this breach of the condition the Directors are pleased to report that Belastock has confirmed its ongoing support for the Company and that it is the current intention of Belastock to subscribe for the remaining tranches of the Notes as previously outlined. The second tranche of the Notes, which should raise approximately £255,000 (net of expenses), are due to be issued in mid-July.

Further announcements will be made as appropriate.

 

 

**ENDS**

 

For further information visit www.kinwellness.com

 

Contact:

 

Anna Gudmundson / Donald Stewart

 

Kin Group Plc

020 7449 4949

Mark Brady / Neil Baldwin

 

SPARK Advisory Partners Limited (Nominated Advisor)

 

020 3368 3551

Claire Louise Noyce

Hybridan LLP, Broker

020 3764 2341

 

Stephanie Forrest

T/F/D, Public Relations

07917 695755

 

Notes

About Kin Wellness

 

Kin Wellness provides digital wellness solutions that empower employers to create a positive culture of health within their organisation. By helping employees to embrace a healthier way of living, Kin Wellness can help maximise performance, reduce absenteeism, decrease the risk of chronic illness, and lower healthcare costs.

 

The Company's technological edge allows it to address holistic wellness by engaging both individuals and teams through intelligent, personalised interaction and gamification. This is an opportunity to make incremental behavioural changes that will last a lifetime. The progress of individuals translates to actionable data, meaningful reporting and insights that allow the organisation to monitor the impact of the programme and to refine it in order to achieve success.

 

Shares are admitted to trading on the London Stock Exchange AIM market under ticker KIN.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODOKBDPCBKDOAD
Date   Source Headline
22nd Apr 20217:00 amRNSAnnual General Meeting Statement
7th Apr 20214:41 pmRNSSecond Price Monitoring Extn
7th Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20216:11 pmRNSPosting of Annual Report & Accounts, Notice of AGM
26th Mar 20217:00 amRNSPreliminary Results for the y/e 31 December 2020
12th Feb 202110:00 amRNSBidstack teams up with Moat by Oracle
2nd Feb 20219:05 amRNSSecond Price Monitoring Extn
2nd Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSTrading Update and Directorate Change
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:00 amRNSPrice Monitoring Extension
6th Jan 20212:05 pmRNSSecond Price Monitoring Extn
6th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 202111:05 amRNSSecond Price Monitoring Extn
6th Jan 202111:00 amRNSPrice Monitoring Extension
4th Jan 20214:41 pmRNSSecond Price Monitoring Extn
4th Jan 20214:36 pmRNSPrice Monitoring Extension
4th Jan 20212:06 pmRNSSecond Price Monitoring Extn
4th Jan 20212:00 pmRNSPrice Monitoring Extension
4th Jan 202111:05 amRNSSecond Price Monitoring Extn
4th Jan 202111:00 amRNSPrice Monitoring Extension
23rd Dec 20205:15 pmRNSBlock Listing Six Monthly Return
21st Dec 202011:00 amRNSPrice Monitoring Extension
17th Dec 20209:05 amRNSSecond Price Monitoring Extn
17th Dec 20209:00 amRNSPrice Monitoring Extension
17th Dec 20207:00 amRNSTrading Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20202:40 pmRNSExercise of Warrants, Issue of Equity and TVR
11th Nov 20202:51 pmRNSExercise of Warrants, Issue of Equity and TVR
29th Oct 20201:20 pmRNSExercise of Warrants and Total Voting Rights
27th Oct 20208:38 amRNSBlock Listing Six Monthly Return
2nd Oct 20204:35 pmRNSPrice Monitoring Extension
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
24th Sep 20209:05 amRNSSecond Price Monitoring Extn
24th Sep 20209:00 amRNSPrice Monitoring Extension
23rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
23rd Sep 20204:35 pmRNSPrice Monitoring Extension
15th Sep 202011:05 amRNSSecond Price Monitoring Extn
15th Sep 202011:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSExclusive Agreement with Ubisoft for Hyper Scape
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20204:40 pmRNSSecond Price Monitoring Extn
18th Aug 20204:35 pmRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSInterim Results
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.